Philip J. Mease
Philip J. Mease publishes mostly in Rheumatology, Immunology and Hematology, on topics such as Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies and Psoriasis: Treatment and Pathogenesis.
- World rank
- #87,190 of 7,710,434 ranked researchers
- Rank in United States
- #33,685 of 1,627,098
- Works
- 1,144
- Citations
- 79k
- Citations per work
- 69.1
What does Philip J. Mease research?
Philip J. Mease's work is mostly in Medicine (63%), Immunology and Microbiology (22%), Economics, Econometrics and Finance (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences72563.4%
- Medicine72563.4%
- Life Sciences24921.8%
- Immunology and Microbiology24921.8%
- Everything else15213.3%
- Social Sciences171.5%
- 1Rheumatology49% of their works
- 2Immunology22% of their works
- 3Hematology8% of their works
- 4Psychiatry and Mental health4% of their works
- 5Pharmacology2% of their works
- 6Economics and Econometrics2% of their works
Research topics
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Psoriasis: Treatment and Pathogenesis
- Autoimmune and Inflammatory Disorders Research
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Musculoskeletal pain and rehabilitation
- Health Systems, Economic Evaluations, Quality of Life
- Systemic Lupus Erythematosus Research
Which keywords describe Philip J. Mease's research?
The keywords of their largest research topics: Ankylosing Spondylitis, Spondyloarthritis, Autoantibodies, Inflammation, Rheumatoid Arthritis, IL-17, TH17 Cells and Hemophagocytic Lymphohistiocytosis.
- Antiphospholipid Syndrome
- Cost-effectiveness Analysis
- Chronic Pain
- Chronic Fatigue Syndrome
- Epidemiology
- Hemophagocytic Lymphohistiocytosis
- IL-17
- Inflammation
- Spondyloarthritis
- Ankylosing Spondylitis
- Autoantibodies
- Rheumatoid Arthritis
- TH17 Cells
- Juvenile Idiopathic Arthritis
- Psychological Factors
- Fibromyalgia
- Global Burden
- Quality of Life
- Systemic Lupus Erythematosus
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Ankylosing Spondylitis8321 topic
- Spondyloarthritis8321 topic
- Autoantibodies7322 topics
- Inflammation7011 topic
- Rheumatoid Arthritis7011 topic
- IL-176651 topic
- TH17 Cells6651 topic
- Hemophagocytic Lymphohistiocytosis2411 topic
- Juvenile Idiopathic Arthritis2411 topic
- Epidemiology1722 topics
- Psychological Factors1722 topics
- Chronic Fatigue Syndrome1201 topic
- Fibromyalgia1201 topic
- Chronic Pain521 topic
- Global Burden521 topic
- Cost-effectiveness Analysis451 topic
- Quality of Life451 topic
- Antiphospholipid Syndrome311 topic
- Systemic Lupus Erythematosus311 topic
Where does Philip J. Mease work?
Philip J. Mease's main affiliation in the publication record is University of Washington, United States.
How many publications and citations does Philip J. Mease have?
OpenAlex counts 1,144 works and 79,078 citations for Philip J. Mease, an h-index of 119, ranking #87,190 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Philip J. Mease. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.